PET/MRI in Infection and Inflammation

• Published in: Seminars in nuclear medicine Vol. 48; no. 3; pp. 225 - 241
• Main Authors: Sollini, Martina, Berchiolli, Raffaella, Kirienko, Margarita, Rossi, Alexia, Glaudemans, A.W.J.M., Slart, Riemer, Erba, Paola Anna
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.05.2018
• ISSN: 0001-2998; 1558-4623
• DOI: 10.1053/j.semnuclmed.2018.02.003

Hybrid positron emission tomography/magnetic resonance imaging (PET/MR) systems are now more and more available for clinical use. PET/MR combines the unique features of MR including excellent soft tissue contrast, diffusion-weighted imaging, dynamic contrast-enhanced imaging, fMRI and other specialized sequences as well as MR spectroscopy with the quantitative physiologic information that is provided by PET. Most of the evidence of the potential clinical utility of PET/MRI is available for neuroimaging. Other areas, where PET/MR can play a larger role include head and neck, upper abdominal, and pelvic tumours. Although the role of PET/MR in infection and inflammation of the cardiovascular system and in musculoskeletal applications are promising, these areas of clinical investigation are still in the early phase and it may be a little longer before these areas reach their full potential in clinical practice. In this review, we outline the potential of hybrid PET/MR for imaging infection and inflammation. A background to the main radiopharmaceuticals and some technical considerations are also included.